Prolactin-blocking drugs may play a role in reversing or preventing post-partum cardiomyopathy (PPCM), according to US research. Studies in mice showed that those that lacked the gene STAT3, specifically in heart muscle cells, consistently developed PPCM. The researchers then found a similar imbalance in humans. However, prolactin-blocking drugs were found to overcome the heart damage caused by a lack of the gene STAT3. Women with PPCM who were given prolactin-blocking drugs showed an increased heart function and all survived the four-month observation period (Cell Online 2007).
- Salaried GP Fleet Medical Centre Fleet, Hampshire
- General Practitioners East Shore Partnership Portsmouth, Hampshire
- Salaried GP or GP Partnership vacancy Milnthorpe, Cumbria Stoneleigh Surgery Milnthorpe, Cumbria
- Full Time or Part Time Salaried GP or Partnership Failsworth Group Practice Greater Manchester
- PARTNER OR SALARIED GP College Road Surgery Kingstanding, Birmingham